top of page
Browse by category
Search
3.8 billion adults and 746 million children and adolescents predicted to have overweight or obesity by 2050
Without urgent policy reform and action, over half the world's adult population (3.8 billion) and a third of all children and adolescents...
The brain acts as a critical control centre into the origins of type 2 diabetes and obesity
A study by the University Hospital of Tübingen, the German Center for Diabetes Research (Deutsches Zentrum fuer Diabetesforschung, DZD),...
Study demonstrates the relationship between antidepressants and weight gain
A study led by the Hospital del Mar Research Institute IMIM), Barcelona, Spain, has demonstrated the link between antidepressants and...
The Obesity Society commends FDA's resolution of obesity drug shortages and calls for enforcement against unauthorised compounding
The Obesity Society (TOS) has acknowledged the FDA’s recent announcement declaring the end of shortages for Novo Nordisk's Wegovy and...
Researcher 2 Researcher and Bariatric News - The Podcasts
Spend an engaging hour with Researcher 2 Researcher and Bariatric News as we explore a range of topics in Bariatric and Metabolic...
GLP-1 receptor agonists target fat over muscle for weight loss
A research team from the School of Public Health, in the LKS Faculty of Medicine of the University of Hong Kong (HKUMed), who assessed...
Journal Watch 26/2/2025
Welcome to our weekly round-up of the latest bariatric and obesity-related papers published in the medical literature. As ever, we have...
Ten-year SM-BOSS outcomes: RYGB betters LSG for %EBMIL, GERD and revisions
In this randomized clinical trial, RYGB led to significantly higher %EBMIL in the PP population compared to SG beyond 10 years’...
ReShape signs distribution agreement in Canada with Liaison Medical for its next-generation Lap-Band 2.0 FLEX
ReShape Lifesciences has signed a distribution agreement with Liaison Medical for distribution of ReShape’s next generation, enhanced...
Zoledronic acid increases bone mass in the spine and prevents bone loss in the hip after BMS
A randomised clinical trial (RCT) that investigated the effects of zoledronic acid (ZA) for the prevention of bone loss after Roux-en-Y...
Browse by tag
bottom of page